PERV data renew xeno debate
PERV data renew xeno debate
复制标题
DOI:
10.1038/80207
复制
发表时间:
2000-10
影响因子:
46.9
通讯作者:
E. Dorey
中科院分区:
文献类型:
--
作者:
E. Dorey
ANALYSIS research at PPL Therapeutics (Roslin, UK) agrees with Fishman.“It is a model, but it’sa very difficult model to extrapolate from,” says Colman. He explains that it’s not clear that the infectivity had spread to mouse cells and was not just in the pig cells that had entered various organs.“There’sa possibility that what they were assaying was the remnants of the cells that they originally put in those animals,” he says, explaining that completely immunocompromised mice wouldn’t reject foreign tissue in the way a normal mouse would. However, although several companies are working on knocking out the α-1, 3-galactosyl transferase gene so that pig organs don’t prompt acute rejection in humans, patients would still need to be put on immunosuppressives to avoid chronic rejection—something that puts the patient at an increased risk for the development of retroviruses. Nevertheless, Salomon’s findings may not be as discouraging as they first seem because, as Salomon himself points out, even though the mice are severe combined immunodeficient (SCID) they are not sick and there was no evidence for any kind of active viral spread.“All our data suggests is that by the 2 month time point, the virus had already become latent.” In any case, transmission from pigs to mice is a bit of a non-issue, points out Fishman.“The fact that we may or may not be able to infect humans or non-human primates is much closer to the area of concern.” One of the proposed solutions to crossspecies PERV transmission is that cloning be used to generate PERV-free animals after first knocking out or disrupting crucial PERV genes. BioTransplant’s news that peripheral blood cells from one of its line of in-bred mini-swine don’t transmit PERV A or B—2 variants that infect human cells in culture—seems to add credence to this, even though the swine were produced by traditional breeding methods. Although the primary data has yet to be published in a peerreviewed journal, Salomon is enthusiastic about what they suggest.“The scientific impact is way, way beyond the fact that the company accidentally has this pig,” he says. BioTransplant’s chief scientific officer Julia Greenstein says that rationally knocking